Related Experiment Video
Updated: May 10, 2025

07:31
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
6.9K
Development of an Acute Coronary Syndrome-Cardiogenic Shock Risk Score for 30-day Mortality From the Victorian
Nicholas D'Elia1,2, Sara Vogrin3, Angela L Brennan4
1Western Health Department of Cardiology, Victoria, Australia.
Summary
A new risk score accurately predicts 30-day mortality in acute coronary syndrome-cardiogenic shock (ACS-CS) patients undergoing PCI. This simple bedside tool aids rapid prognostication for high-risk individuals.
Area of Science:
- Cardiology
- Clinical Risk Stratification
- Outcomes Research
Background:
- Acute coronary syndrome-cardiogenic shock (ACS-CS) has a high 30-day mortality rate of approximately 50%.
- Effective prognostication is crucial for managing these high-risk patients.
- A simple bedside risk score can aid in rapid risk assessment.
Purpose of the Study:
- To develop and validate a simple bedside risk score for predicting 30-day all-cause mortality in patients with ACS-CS.
- To identify key clinical and procedural predictors of mortality in this population.
Main Methods:
- Analysis of data from 1564 consecutive patients with ACS-CS undergoing percutaneous coronary intervention (PCI) from the Victorian Cardiac Outcomes Registry (VCOR) (2013-2021).
- Internal validation using 1000 bootstrapped samples to identify robust predictors.
- Model performance evaluated using C-statistic and Hosmer-Lemeshow (HL) statistic.
Main Results:
- The study identified key predictors of 30-day mortality including age, female sex, diabetes, reduced estimated glomerular filtration rate, low left ventricular ejection fraction, out-of-hospital cardiac arrest, pre-procedural intubation, mechanical circulatory support, STEMI, and multivessel PCI.
- The validated risk score demonstrated excellent fit and performance (C-statistic = 0.8, HL p = 0.44).
- In-hospital and 30-day mortality rates were 42% and 45%, respectively.
Conclusions:
- A risk score incorporating peri-procedural variables accurately stratifies 30-day mortality risk in ACS-CS patients undergoing PCI.
- The score's simplicity suggests potential for clinical practice translation.
- External validation is recommended for the VCOR ACS-CS risk score.

